News & Info

Cardiovascular Specialists chosen as site for study of diagnostic test effectiveness

Cardiovascular Specialists of Southwest Louisiana was selected as an investigative site for the PROMISE Trial, a study of the effectiveness of tests to detect coronary artery disease. Michael C. Turner, M.D., is principal investigator and Thomas J. Mulhearn IV, M.D., is co-investigator.

 

The PROMISE Trial is funded by the National Heart, Lung and Blood Institute and coordinated by Duke University. The study seeks to answer the question as to which noninvasive tests offer the best long-term results for detecting and treating coronary artery disease. The results of this study will determine to a large extent what test cardiologists choose in evaluating a patient for heart disease. It is the largest comparative effectiveness trial of its kind and will enroll 10,000 patients worldwide.

 

Candidates for this trial are men over 45 and women over 50 who have risk factors for coronary disease, and are considered low to intermediate risk. Subjects are randomized to receive either a routine graded exercise test, myocardial profusion scans, or cardiac CT angiography. These three modalities will be compared for their effectiveness in diagnosing and treating disease.

 

Participation in the study requires the principal investigator to be trained to a level-three status for cardiac CT or to be board-certified in that specialty. Dr. Michael Turner completed level-three requirements in cardiac CT in 2007, and in 2008 became board-certified in cardiovascular CT. He is a founding member of the Society of Cardiovascular CT and was named a fellow of the Society of Cardiovascular CT in June 2010.

 

For information on participation in this study, contact your primary care physician or Cardiovascular Specialists at (337) 436-3813.

Cardiovascular imaging assists in diagnosis

      Advanced tools for cardiovascular imaging can help detect heart disease or other heart problems and can put patients on an effective treatment course.

      Cardiologists use three main types of imaging: the cardiac CT scanner, nuclear myocardial perfusion imaging (nuclear stress test) and echocardiography.

 

Cardiac CT

     Heart and vascular disease represents the number one cause of death and disability in women (as well as men). Sudden cardiac death is all too frequently the first sign of heart disease.  These statistics are real and frightening. They beg the question "what can be done?"

     The answer is PREVENTION. We now have at our disposal the knowledge that healthy lifestyle changes and proper medical management of those at risk can substantially change the outcomes in heart and vascular disease.

     Early detection is the key to prevention. The earlier we can detect and treat heart disease, the better the outcome. Standard risk factor screening can be supplemented with a new and powerful risk assessment tool called calcium scanning. Calcium in the walls of arteries is a marker for plaque and correlates well with the risk of heart attack and death. When detected with a quick CT scan this information can be used to determine how aggressive treatment should be or provide reassurance for those not at high risk. For those with the suspicion of heart disease cardiac CT angiography (with dye) can produce striking pictures of the heart and arteries that can diagnose the presence or absence of disease with astounding accuracy- often years before it can be detected with stress testing. Armed with accurate risk information you and your physician can team up to change your outlook with regard to heart attack and stroke.

 

Cardiac CT Scanner and CT Angiography

     The cardiac CT scanner allows cardiologists to get a full view of every angle of the heart and vascular system. The images are gathered by rotating an X-ray beam system 360 degrees around the body while scanning detailed cross-sections of the heart. A powerful computer then compiles the images into a series of three-dimensional, semi-transparent images.
      CT-angiography, one of the procedures performed with the cardiac CT scanner, is used to diagnose the presence and severity of coronary artery disease.
      “What we get from this scanner is a complete three-dimensional scan of the heart, a virtual trip through the heart using a noninvasive, outpatient procedure,” Dr. Turner said. “This cardiac CT scanner in many instances allows us to gauge the health of the coronary artery system as effectively as an invasive procedure performed in the hospital, and  is actually superior to cardiac catheterization in its ability to look at the anatomy of the heart.”
      According to Dr. Turner, this is an exciting, new technique that will have expanded uses over the next several years.

 

Nuclear Stress Test

   A nuclear stress test is a gold standard test for looking at abnormalities of blood flow to the heart. It is used by doctors to assess the risk of and presence of blockages in the coronary arteries.
The test consists of two parts. The first involves injecting a tracer into the blood stream and then electrodes are placed onto the patient’s chest. The cardiologist then has the patient exercise on a treadmill at gradually increasing speeds and inclines. During this period of time the cardiologist monitors the patient’s heartbeat for abnormalities.
After the exercise portion of the exam is complete the second phase of the test begins. Special cameras that can detect the previously injected tracer are used to take pictures of the heart. The tracer is carried by blood throughout the body and the camera is able to detect the amount of blood flow from the heart.

 

Echocardiography

     An echocardiogram is simply an ultrasound of the heart. The echocardiogram was the first medical application of ultrasound technology, and when combined with a Doppler examination, cardiologists are able to assess blood flow. 
      “Echocardiograms allow us to look at abnormalities of valves and heart function or blood flow,” Dr. Turner said

 

Calcium Scan of the Heart—A self-referred exam.

     A fourth test is available and patients don’t need a physician’s referral for this one. A calcium scan of the heart is an useful tool for someone who has no known indications of coronary disease.  A calcium score, or the amount of plaque in the arteries, is an excellent way to predict the risk of a future heart attack.
      “If a patient has a very low calcium score then their ten year risk of a heart attack is very low,” said Dr. Turner. “Conversely, if a patient has a high calcium score (more than 400) then their ten year risk of a coronary event may be as high as 20 percent.”
      A calcium scan is independent of and can be used in addition to traditional risk factors to predict a heart attack.

Early Detection Saves Lives
      With this imaging technology, cardiologists are able to add new meaning to the words “early detection.”
      These imaging tests often complement each other and one may suggest a problem that another test can confirm.
      “Just like many other diseases, early detection can mean the difference between life and death,” Dr. Turner added. “It is especially important when dealing with heart disease, however, because often people with heart disease have few visible symptoms, if any at all.”

 

We Welcome Dr. Thomas Mulhearn

Thomas Mulhearn, MD

June 1, 2011—We are pleased to welcome Thomas J. Mulhearn IV, MD, to the practice of cardiology.

     Dr. Mulhearn maintains office hours at Cardiovascular Specialists’ Lake Charles and Sulphur offices, and he is on the medical staffs at Christus St. Patrick and West Calcasieu Cameron hospitals.

     Dr. Mulhearn provides general cardiology care and specializes in interventional cardiology, which focuses on the diagnosis and treatment of the heart and vascular disease via cardiac catheterization, using procedures such as angioplasty and stent placement.

     Dr. Mulhearn, a native of Southwest Louisiana and graduate of Barbe High School, has recently returned to his hometown after completing specialized training at some of the world’s most highly respected medical centers. He is board-certified in cardiovascular disease, and completed a fellowship in cardiovascular disease at the Duke University School of Medicine and a fellowship in interventional cardiology at the University of Alabama Birmingham. Dr. Mulhearn performed his internship and residency at the Johns Hopkins Hospital in the Osler Medical Housestaff Training Program. He received his Doctor of Medicine degree from Louisiana State University School of Medicine in New Orleans and a Bachelor of Science degree from Louisiana State University.

 

 

 

Disclaimer: The intent and purpose of this website is for educational usage only. If you are concerned that you may have a medical condition or experiencing any symptoms that could indicate a medical condition, contact your physician of record immediately or go to your local emergency center for treatment.